These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30748038)

  • 1. "It is not just any pill"-Women's experiences of endocrine therapy after breast cancer surgery.
    Ahlstedt Karlsson S; Wallengren C; Olofsson Bagge R; Henoch I
    Eur J Cancer Care (Engl); 2019 May; 28(3):e13009. PubMed ID: 30748038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer.
    Harrow A; Dryden R; McCowan C; Radley A; Parsons M; Thompson AM; Wells M
    BMJ Open; 2014 Jun; 4(6):e005285. PubMed ID: 24928595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding tamoxifen adherence in women with breast cancer: A qualitative study.
    Moon Z; Moss-Morris R; Hunter MS; Hughes LD
    Br J Health Psychol; 2017 Nov; 22(4):978-997. PubMed ID: 28850763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segmental mastectomy and tamoxifen alone provide adequate locoregional control of breast cancer in elderly women.
    Yeh S; Tan LR; O'Connell TX
    Am Surg; 1997 Oct; 63(10):854-7. PubMed ID: 9322656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of breast cancer in countries with limited resources.
    Carlson RW; Anderson BO; Chopra R; Eniu AE; Jakesz R; Love RR; Masetti R; Schwartsmann G;
    Breast J; 2003; 9 Suppl 2():S67-74. PubMed ID: 12713499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence.
    Heisig SR; Shedden-Mora MC; von Blanckenburg P; Schuricht F; Rief W; Albert US; Nestoriuc Y
    Psychooncology; 2015 Feb; 24(2):130-7. PubMed ID: 24953538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choices in cancer treatment: a qualitative study of the older women's (>70 years) perspective.
    Husain LS; Collins K; Reed M; Wyld L
    Psychooncology; 2008 Apr; 17(4):410-6. PubMed ID: 17847124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K
    Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour.
    Cahir C; Dombrowski SU; Kelly CM; Kennedy MJ; Bennett K; Sharp L
    Support Care Cancer; 2015 Nov; 23(11):3115-30. PubMed ID: 25744290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.
    Avril A; Le Bouëdec G; Lorimier G; Classe JM; Tunon-de-Lara C; Giard S; MacGrogan G; Debled M; Mathoulin-Pélissier S; Mauriac L;
    Eur J Surg Oncol; 2011 Jul; 37(7):563-70. PubMed ID: 21665421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine therapy for breast cancer: assessing an array of women's treatment experiences and perceptions, their perceived self-efficacy and nonadherence.
    Wouters H; Stiggelbout AM; Bouvy ML; Maatman GA; Van Geffen EC; Vree R; Nortier JW; Van Dijk L
    Clin Breast Cancer; 2014 Dec; 14(6):460-467.e2. PubMed ID: 24981234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer.
    Fowble B; Fein DA; Hanlon AL; Eisenberg BL; Hoffman JP; Sigurdson ER; Daly MB; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):669-77. PubMed ID: 8690632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review and meta-synthesis of the qualitative literature using grounded theory.
    AlOmeir O; Patel N; Donyai P
    Support Care Cancer; 2020 Nov; 28(11):5075-5084. PubMed ID: 32601852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of patients with hormone receptor-positive breast cancer who need adjuvant tamoxifen therapy for more than 5 years.
    Wu CE; Chen SC; Chang HK; Lo YF; Hsueh S; Lin YC
    J Formos Med Assoc; 2016 Apr; 115(4):249-56. PubMed ID: 25900861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disentangling breast cancer patients' perceptions and experiences with regard to endocrine therapy: nature and relevance for non-adherence.
    Wouters H; van Geffen EC; Baas-Thijssen MC; Krol-Warmerdam EM; Stiggelbout AM; Belitser S; Bouvy ML; van Dijk L
    Breast; 2013 Oct; 22(5):661-6. PubMed ID: 23770134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
    Kuba S; Maeda S; Matsumoto M; Yamanouchi K; Yano H; Morita M; Sakimura C; Hatachi T; Tokai Y; Takatsuki M; Fujioka H; Hayashida N; Nagayasu T; Eguchi S
    Clin Breast Cancer; 2018 Apr; 18(2):150-156. PubMed ID: 29290564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Organ preserving treatment of breast cancer].
    Topuzov EG; Krasnozhon DA
    Vestn Khir Im I I Grek; 2004; 163(3):99-102. PubMed ID: 15317177
    [No Abstract]   [Full Text] [Related]  

  • 20. Audit of a conservative management policy of the axilla in elderly patients with operable breast cancer.
    al-Hilaly M; Willsher PC; Robertson JF; Blamey RW
    Eur J Surg Oncol; 1997 Aug; 23(4):339-40. PubMed ID: 9315064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.